Abstract
Introduction
Endometrial cancer (EC) and colorectal cancer (CRC) may share a common genetic background. In a subset of patients, the two malignancies can coexist either at the time of diagnosis (synchronous) or develop consequently (metachronous). The purpose of this nationwide, population-based study was to investigate the occurrence and clinical outcomes of synchronous/metachronous EC/CRC in Taiwanese women.
Materials and methods
Data for women diagnosed with EC and/or CRC between 2007 and 2015 were retrospectively retrieved from the nationwide Taiwan Cancer Registry. Mortality data were obtained from the National Death Registry. Women with synchronous/metachronous EC/CRC versus EC or CRC were compared in terms of clinical characteristics and outcomes.
Results
Of the 62,764 Taiwanese women diagnosed with EC and/or CRC during the study period, 167 (0.3%) had synchronous/metachronous EC/CRC. Among them, 72 cases (43.1%) presented with EC followed by CRC, 66 (39.5%) with CRC followed by EC, and 29 (17.4%) with synchronous EC/CRC. Kaplan–Meier estimates for time-to-event data revealed that the 2-year risk rates of develo** a metachronous tumor of interest (CRC or EC) in women diagnosed with an initial EC and CRC were 39.6% and 42.1%, respectively. The 5-year overall survival rates of women with metachronous EC/CRC who had an initial diagnosis of EC, CRC, and synchronous EC/CRC were 73.9%, 70.9%, and 37.0%, respectively.
Conclusions
Endometrial cancer is the most common first tumor in Taiwanese women with metachronous EC/CRC. The 2-year risk rates of develo** a metachronous tumor of interest (CRC or EC) in women diagnosed with an initial EC and CRC are not negligible. Surveillance for CRC is recommended for all women diagnosed with EC. The clinical outcomes of synchronous EC/CRC are markedly less favorable.
Similar content being viewed by others
Abbreviations
- CRC:
-
Colorectal cancer
- EC:
-
Endometrial cancer
- MMR:
-
Mismatch repair
- LC:
-
Lynch syndrome
- NDR:
-
National Death Registry
- TCR:
-
Taiwan Cancer Registry
References
Lortet-Tieulent J, Ferlay J, Bray F, Jemal A (2018) International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst 110(4):354–361
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33
(2015) Health promotion administration ministry of health and welfare Taiwan. 2012 Cancer registry annual report, Taiwan
(2020) Health promotion administration ministry of health and welfare Taiwan. 2018 Cancer registry annual report, Taiwan
WHO Classification of Tumours Editorial Board. Female genital tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series). http://publications.iarc.fr/592, vol. 4, 5th edn; 2020
Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73
Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP (2015) Milestones of lynch syndrome: 1895–2015. Nat Rev Cancer 15(3):181–194
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP et al (2015) Female hormonal factors and the risk of endometrial cancer in Lynch syndrome. JAMA 314(1):61–71
Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268
Lynch HT, Lynch J (2000) Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol 18(21 Suppl):19S-31S
Anagnostopoulos A, McKay VH, Cooper I, Campbell F, Greenhalgh L, Kirwan J (2017) Identifying Lynch syndrome in women presenting with endometrial carcinoma under the age of 50 years. Int J Gynecol Cancer 27(5):931–937
Barrow E, Hill J, Evans DG (2013) Cancer risk in Lynch syndrome. Fam Cancer 12(2):229–240
Manchana T, Ariyasriwatana C, Triratanachat S, Phowthongkum P (2021) Lynch syndrome in Thai endometrial cancer patients. Asian Pac J Cancer Prev 22(5):1477–1483
Jia S, Wu X, Zhang Y, Zhang M (2021) Chinese Lynch syndrome-associated colorectal cancer patients’ self-concept and adherence to surveillance. Eur J Cancer Care (Engl) 30(2):e13379
Chiang CJ, Wang YW, Lee WC (2019) Taiwan’s Nationwide Cancer Registry system of 40 years: past, present, and future. J Formos Med Assoc 118(5):856–858
Kavuluru R, Hands I, Durbin EB, Witt L (2013) Automatic extraction of ICD-O-3 primary sites from cancer pathology reports. AMIA Jt Summits Transl Sci Proc 2013:112–116
Lu TH, Lee MC, Chou MC (2000) Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 29(2):336–343
Tibiletti MG, Carnevali I, Calo V, Cini G, Lucci Cordisco E, Remo A et al (2021) Universal testing for MSI/MMR status in colorectal and endometrial cancers to identify Lynch syndrome cases: state of the art in Italy and consensus recommendations from the Italian Association for the Study of Familial Gastrointestinal Tumors (AIFEG). Eur J Cancer Prev
Ryan NA, McMahon RF, Ramchander NC, Seif MW, Evans DG, Crosbie EJ (2021) Lynch syndrome for the gynaecologist. Obstet Gynaecol 23(1):9–20
Lee KD, Chen CY, Huang HJ, Wang TY, Teng D, Huang SH et al (2015) Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period. BMC Cancer 15:393
Wagner A, Hendriks Y, Meijers-Heijboer EJ, de Leeuw WJ, Morreau H, Hofstra R et al (2001) Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 38(5):318–322
Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127(1):17–25
Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K et al (2014) Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol 32(2):90–100
Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38(11):1501–1509
Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S et al (2005) Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 105(3):569–574
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP et al (2013) Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 105(4):274–279
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218
Li X, Liu G, Wu W (2021) Recent advances in Lynch syndrome. Exp Hematol Oncol 10(1):37
Acknowledgements
This study was financially supported by the Chang Gung Memorial Foundation (Grants CMRPG3J0411/2, 3J0401/02, 3J0381/0382, 3J0391/0392, and CIRPG 3K0031). The authors are grateful to Chu-Chun Huang and Jung-Erh Yang for their excellent technical assistance, and statistical assistance provided by the Clinical Trial Center, Chang Gung Memorial Hospital, Linkou, which was founded by the Ministry of Health and Welfare of Taiwan (MOHW110-TDU-B-212-124005).
Author information
Authors and Affiliations
Contributions
AC and LYY: study concept and design. AC, RCW, and ASC: literature review; WYC and LYY: data analysis. AC, RCW, CHW, and LYY: manuscript writing. AC and CHL: critical revision of the manuscript for important intellectual content. All authors approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
Ethics approval was received from the Institutional Review Board of the Chang Gung Medical Foundation (Approval No: 201801202B0C502).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chao, A., Wu, RC., Chao, AS. et al. Synchronous/metachronous endometrial and colorectal malignancies in Taiwanese women: a population-based nationwide study. Arch Gynecol Obstet 306, 165–172 (2022). https://doi.org/10.1007/s00404-021-06296-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-021-06296-0